Current recommendations for preventing relapse of GERD symptoms in pediatric patients after healing of reflux esophagitis include ≥6 months' maintenance therapy with PPIs such as omeprazole.

Omeprazole is a medication used to treat stomach and esophagus conditions. Known as a proton pump inhibitor, omeprazole is sold over-the-counter and in stronger doses with a prescription.

Objective: To investigate the relative bioavailability and bioequivalence, in fasting and fed conditions, of repeated doses of two omeprazole enteric-coated formulations in healthy volunteers.